Peter Clausi



Moovly Media Inc.
Latest Comments
image_pdfimage_print

Thomas Smeenk with an update on the FDA Phase II clinical trial program of the Hemostemix blood-derived, stem cell therapeutics product (ACP-01)

In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV: HEM | […]


Dev Randhawa on Fission 3.0 and why ESG Investors are looking at Uranium

In a recent InvestorIntel interview, Peter Clausi speaks with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp. (TSXV: FUU […]


Silver Bullet Mines’ Peter Clausi on preparing to trade and the race to production

In a recent InvestorIntel interview, Tracy Weslosky speaks with Peter Clausi, VP Capital Markets of Silver Bullet Mines Inc. (TSXV: […]


Marcy Kiesman on Durango’s Discovery property in one of the most prolific gold camps in Quebec

In a recent InvestorIntel interview, Peter Clausi speaks with Marcy Kiesman, CEO and Chair of Durango Resources Inc. (TSXV: DGO […]


Joel Freudman on TRU Precious Metals’ 5 gold exploration projects in the Newfoundland Gold Belt

In a recent InvestorIntel interview, Peter Clausi spoke with Joel Freudman, Co-Founder, President, and CEO of TRU Precious Metals Corp. […]


Brendon Grunewald on rising demand for Moovly’s cloud-based video tools and the partnerships driving sales forward

In a recent InvestorIntel interview with host Peter Clausi, Brendon Grunewald CEO and Director of Moovly Media Inc. (TSXV: MVY) […]


InvestorIntel’s Peter Clausi interviews Chris Thompson on the eResearch Initiation Equity Research Report on Renforth Resources

In a recent InvestorIntel interview, Peter Clausi spoke with Chris Thompson, President of eResearch Corp. about his 29-Page Initiation Equity […]